E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/16/2006 in the Prospect News Biotech Daily.

New Issue: Hansen raises $75 million in IPO of 6.25 million shares at $12 each - middle of talk at $11-$13

By Ronda Fears

Memphis, Nov. 16 - Hansen Medical, Inc. raised $75 million from its initial public offering of 6.25 million shares at $12 each, the middle of guidance of $11 to $13 per share, via joint bookrunners Morgan Stanley & Co. and J.P. Morgan Securities Inc.

The Mountain View, Calif.-based company, which develops and manufactures robotics designed to position, manipulate and control catheter technologies, plans to use proceeds for sales, marketing and general corporate purposes.

Issuer:Hansen Medical, Inc.
Issue:Initial public offering
Gross proceeds:$75 million
Net proceeds:$69.75 million
Shares:6.25 million
Greenshoe:937,500 shares
Price:$12 per share
Price talk:$11 to $13 per share
Joint bookrunners:Morgan Stanley & Co. and J.P. Morgan Securities Inc.
Co-managers:Thomas Weisel Partners LLC and Leerink Swann & Co.
Pricing date:Nov. 15
Settlement date:Nov. 21
Stock symbol:Nasdaq: HNSN

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.